Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenobarbital sodium 7.5mg/5ml oral liquid
0408010P0AABJBJ
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenytoin 300mg/5ml oral liquid
0408010Z0AABHBH
|
Phenytoin | Phenytoin | Central Nervous System | No data available |
|
Phenytoin sodium 400mg/5ml oral liquid
0408010Q0AAAZAZ
|
Phenytoin sodium (Systemic) | Phenytoin sodium | Central Nervous System | No data available |
|
Phenytoin sodium 50mg tablets
0408010Q0AAAFAF
|
Phenytoin sodium (Systemic) | Phenytoin sodium | Central Nervous System | No data available |
|
Phenytoin sodium 54mg/5ml oral suspension
0408010Q0AABABA
|
Phenytoin sodium (Systemic) | Phenytoin sodium | Central Nervous System | No data available |
|
Phenytoin sodium 84mg/5ml oral liquid
0408010Q0AAAVAV
|
Phenytoin sodium (Systemic) | Phenytoin sodium | Central Nervous System | No data available |
|
Physeptone 20mg/2ml solution for injection ampoules
0407020M0BBACA3
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 35mg/3.5ml solution for injection ampoules
0407020M0BBADAT
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/2ml solution for injection ampoules
0407020M0BBAHA6
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Physeptone 50mg/5ml solution for injection ampoules
0407020M0BBAEAN
|
Physeptone (Opioid Analgesic) | Methadone hydrochloride | Central Nervous System | No data available |
|
Pimozide 1.25mg/5ml oral suspension
0402010R0AAAGAG
|
Pimozide | Pimozide | Central Nervous System | No data available |
|
Pimozide 2mg tablets
0402010R0AAAAAA
|
Pimozide | Pimozide | Central Nervous System | No data available |
|
Piportil Depot 100mg/2ml solution for injection ampoules
0402020V0BBABAB
|
Piportil Depot | Pipotiazine palmitate | Central Nervous System | No data available |
|
Piportil Depot 50mg/1ml solution for injection ampoules
0402020V0BBAAAA
|
Piportil Depot | Pipotiazine palmitate | Central Nervous System | No data available |
|
Pipotiazine 100mg/2ml solution for injection ampoules
0402020V0AAABAB
|
Pipotiazine palmitate | Pipotiazine palmitate | Central Nervous System | No data available |
|
Pipotiazine 50mg/1ml solution for injection ampoules
0402020V0AAAAAA
|
Pipotiazine palmitate | Pipotiazine palmitate | Central Nervous System | No data available |
|
Pizotifen 1mg/5ml oral suspension
0407042Q0AAAHAH
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 250micrograms/5ml oral solution sugar free
0407042Q0AAAAAA
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 500micrograms/5ml oral suspension
0407042Q0AAAFAF
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Pizotifen 750micrograms/5ml oral suspension
0407042Q0AAAGAG
|
Pizotifen malate | Pizotifen malate | Central Nervous System | No data available |
|
Potassium bromide mixture
0401010S0AAABAB
|
Potassium bromide | Potassium bromide | Central Nervous System | No data available |
|
Prazine 25mg tablets
0402010S0BDAAAE
|
Prazine | Promazine hydrochloride | Central Nervous System | No data available |
|
Pregabalin 200mg/5ml oral liquid
0408010AEAAAKAK
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 25mg/5ml oral liquid
0408010AEAAAMAM
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
|
Pregabalin 300mg/5ml oral suspension
0408010AEAAARAR
|
Pregabalin | Pregabalin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.